Badreddin Edris - 03 Mar 2025 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
03 Mar 2025
Net transactions value
-$1,084,592
Form type
4
Filing time
05 Mar 2025, 18:33:49 UTC
Previous filing
12 Feb 2025
Next filing
18 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale $208,450 -3,924 -2.1% $53.12 185,788 03 Mar 2025 Direct F1, F2
transaction SWTX Common Stock Sale $655,331 -12,078 -6.5% $54.26 173,710 03 Mar 2025 Direct F1, F3
transaction SWTX Common Stock Sale $198,331 -3,598 -2.1% $55.12 170,112 03 Mar 2025 Direct F1, F4
transaction SWTX Common Stock Sale $22,481 -400 -0.24% $56.20 169,712 03 Mar 2025 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.725 to $53.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.74 to $55.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $56.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.